P-选择素与糖尿病血管并发症及中医药干预治疗的研究进展
出处
《中国医师杂志》
CAS
2006年第10期1438-1439,共2页
Journal of Chinese Physician
参考文献19
-
1Fijnheer R,Frijns CJ,Korteweg J,et al.The origin of P-selectin as a circulating plasma protein.Thromb Haemost,1997,77 (6):1081-1085.
-
2Pongratz G,Brandt-Pohlmann M,Henneke KH,et al.Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation.Chest,1997,111 (4):929-933.
-
3Sedlmayr P,Grosshaupt B,Muntean W.Flow cytometric detection of intracellular platelet antigens.Cytometry,1996,23 (4):284-289.
-
4Semenov AV,Kogan-Ponomarev MIa,Ruda Mia,et al.Soluble P-selectin-a marker of platelet activation and vessel wall injury:increase of soluble P-selectin in plasma of patients with myocardial infarction,massive atherosclerosis and primary pulmonary hypertension.Ter Arkh,2000,72 (4):15-20.
-
5Nomura S,Shouzu A,Omoto S,et al.Activated platelet and oxidized LDL induce endothelial membrane vesiculation:clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes.Clin Appl Thromb Hemost,2004,10(3):205-215.
-
6Keating FK,Whitaker DA,Kabbani SS,et al.Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis.Am J Cardiol,2004,94 (6):725-728.
-
7Wang ZY,Shi JM,Han Y,et al.Comparative study of platelet activation marker in diabetes mellitus patients complicated by cerebrovascular disease.Blood Coagul Fibrinol,2001,12:31-537.
-
8Blann AD,Noteboom WM,Rosendaal FR.Increased soluble P-selectin levels following deep venous thrombosis:cause or effect? Br J Haematol,2000,108 (1):191-193.
-
9Ouvina S M,La Greca R D,Zanaro N L,et al.Endothelial dysfunction,nitric oxide and platelet activation in hypertensive and diabetic type Ⅱ patients.Thromb Res,2001,15; 102 (2):107-114.
-
10Yngen M,Ostenson CG,Hu H.et al.Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy:evidence for platelet hyperactivity and chronic inflammation.Diabetologia,2004,47 (3):537-540.
二级参考文献12
-
1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量：33020
-
2脑卒中患者临床神经功能缺损程度评分标准（1995）[J].中华神经科杂志,1996,29(6):381-383. 被引量：15747
-
3Minamino T,Kitakaze M,Asanuma H,et al.Plasma adenosine levels and platelet activation in patients with atrial fibrillation[].The American Journal of Cardiology.1999
-
4Kahn SR,Solymoss S,Flagel KM.Nonvalvular atrial fibrillation: evidence for a prethrombotic state[].Canadian Medical Association Journal.1997
-
5Kamiyama N.Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation: rabbit experimental model[].Japanese Circulation Journal.1998
-
6Pongratz G,Pohlmann BM,Henneke H,et al.Platelet activation in embolic and prembolic status of patients with nonrheumatic atrial fibrillation[].Chest.1997
-
7Lip GY,Lowe GD,Rumley A,et al.Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment[].British Heart Journal.1995
-
8王淑娟.关于选择血栓前状态实验诊断指标的建议[J].中华医学检验杂志,1998,21(5):305-307. 被引量：89
-
9曹晓岚.清开灵治疗中风病的研究[J].中国中医急症,1999,8(4):176-181. 被引量：6
-
10陆建明.急性脑梗死患者治疗前后血清IL-2、IL-6和TNF水平的变化[J].临床神经病学杂志,1999,12(6):369-369. 被引量：14
共引文献83
-
1张磊,齐秀英.2型糖尿病血脂异常与血管并发症的关系[J].天津医科大学学报,2004,10(S1):20-22.
-
2李莉,李东,黄继华,肖华,古曦,杨芳炬.注射用清开灵冻干粉抗炎及免疫调节作用研究[J].中药药理与临床,2008,24(5):59-60. 被引量：4
-
3史国辉,马绍杰.2型糖尿病并发肾损害危险因素分析[J].华北煤炭医学院学报,2004,6(5):567-568.
-
4崔岚,祝德秋,陶达人.葛根素药理作用研究进展[J].中国药师,2004,7(12):924-927. 被引量：41
-
5王爱民,雷闽湘,刘泽灏,张军,陈卓雄,孙曙光.2型糖尿病肾病危险因素分析[J].中国现代医学杂志,2005,15(1):116-119. 被引量：28
-
6王彤宇,田桂玲,程焱,梁浩.OX-LDL和PON-1与老年动脉粥样硬化性脑梗死的关系[J].天津医药,2005,33(3):151-154. 被引量：1
-
7高剑峰,周友龙,李建生.肿瘤坏死因子介导脑缺血损伤与中医药干预研究的现状[J].中国中西医结合急救杂志,2005,12(2):125-128. 被引量：6
-
8王翠珍,林丽香,陈刚,庄维特,林苗,温俊平,林庆明.2型糖尿病大鼠肾脏组织氧化应激相关基因的表达[J].海峡预防医学杂志,2005,11(2):3-5. 被引量：5
-
9张艳玲,周苏宁.P-选择素表达与心血管事件的中医药研究进展[J].中西医结合心脑血管病杂志,2005,3(5):428-429.
-
10赵丽芸,贾妮,陈镜合.细胞黏附分子与动脉粥样硬化的关系及中药对其表达的调节作用[J].甘肃中医,2005,18(6):2-5. 被引量：1
-
1伍菲,文格波.转录因子NF-κB和糖尿病血管病变[J].美国中华临床医学杂志,2004,6(3):268-269.
-
2朱晓津,方朝晖.SDF-1及受体CXCR4与糖尿病血管病变的研究概述[J].中医药临床杂志,2011,23(8):743-745. 被引量：5
-
3陈沐,李惠仙,龙毓灵.血小板膜上GMP-140表达水平在老年癌症患者中的临床意义[J].昆明医学院学报,2001,22(2):77-78.
-
4官成浓,徐军发,银正民,潘达超,谢杰荣.中晚期原发性肝癌患者血浆可溶性P-选择素的测定及临床意义[J].癌症,2000,19(3):256-258. 被引量：19
-
5李晓红,杨红英.氧化应激与糖尿病血管病变的相关性研究[J].实用糖尿病杂志,2009,5(4):6-7. 被引量：1
-
6肖国华,王宗保.PKB/Akt在糖尿病及其血管并发症中的调节作用[J].医学研究杂志,2010,39(1):13-16. 被引量：3
-
7张春,刘吉成.E-选择素在结肠癌中的研究现状[J].齐齐哈尔医学院学报,2008,29(20):2502-2504. 被引量：1
-
8夏静波.胃癌患者手术前后血浆可溶性P-选择素水平的观察[J].淮海医药,2003,21(5):377-377.
-
9徐宁.复方丹参注射液对2型糖尿病合并高纤维蛋白原血症的疗效评价[J].浙江中医杂志,2009,44(2):145-145.
-
10沈庆乐,张存琪.血清基质金属蛋白酶与糖尿病血管病变的关系[J].微循环技术杂志（临床与实验）,2004,8(5):349-349. 被引量：19
